Please share:

What Does “NNT” Mean and Why Should You Care?

As you might have noticed, I often use the Number Needed to Treat (NNT) to communicate research results. While I strive to write evidence-based but easy-to-understand articles, I believe the NNT is a research concept every GP should know.

  • What is the NNT? It’s the number of patients you need to treat to prevent one bad outcome.
  • How to calculate it? 1 divided by the “absolute risk reduction” (= the risk in the control group minus the risk in the intervention group).

For further explanations, see the University of Oxford or simply Wikipedia. Alternatively, you can watch this great and easy to understand 9-min-Video by Dr Roger Seheult from MedCram.

Now, some context: The NNT was first introduced in the NEJM in 1988 as a useful measure to communicate and prioritize medical treatments. However, a 2020 analysis of 875 clinical trials showed that only 9% reported an NNT.

Key points about NNT

  • Time-wise variation: NNT can vary significantly when applied to different time periods (e.g., 1 year vs. 10 years). A shorter time frame usually leads to a higher NNT, and vice versa.
  • Baseline risk: NNT depends on the average baseline risk of study participants, which can differ in real life patients. A lower baseline risk usually leads to a higher NNT, and vice versa.
  • Comparison group: NNT is influenced by the specific comparator used, like a placebo or another treatment, which may strongly affect its magnitude.
  • Confidence interval: NNT also has a confidence interval (e.g., NNT=10, 95% CI 5 to 15), which is often not reported.
  • Similar Concepts: Number Needed to Harm (NNH) and Number Needed to Screen (NNS) are the equivalents for adverse effects and screenings.

My thoughts

NNT is a valuable tool for realistically assessing treatment effects but has limitations.

Disclaimer: This site and its related services are for informational purposes only and do not provide medical advice. The use of any information provided is solely at your own risk. Neither the site owner nor site contributors can accept responsibility for any loss, damage or injury that arises from the use of this website or services. More information here.

Essential Updates
“exciting, practical, evidence-based, short”
2-min reads by & for GPs.
Free, no pharma money.

More Info & Sign-up.

More to explore

The Landmark PSA Study is Back: Benefits are Real, but Worth the Harm?

The long-awaited 23-year results of the European Prostate Cancer Screening Study (ERSPC) are finally here. PSA screening saves about 2 lives per 1,000 men but leads to 27 extra diagnoses—highlighting the tough balance between benefit and harm. This update breaks down the numbers, explains why the debate continues, and offers practical tips for shared decision-making in…

Is Lecanemab effective against Alzheimer’s?

Lecanemab, a new Alzheimer’s drug, recently gained EMA approval. But how effective is it really, considering the data shows only modest cognitive decline reduction and significant side effects like brain edema?

Is the “Surprise Question” meaningful?

The “Surprise Question” is a quick tool for assessing prognosis in palliative care. But is this common gut-check reliable? Have a look at the evidence!
Stars of Medicine

8 Reasons Why Family Physicians are the Actual Stars of Medicine

I am convinced GPs are the backbone of effective healthcare systems. Here you can find an easy-to-read review of the evidence – which undoubtedly supports this claim!

The 7 Habits of Great Family Doctors.

What makes a great family doctor? We asked 468 GPs from 48 countries to share their best professional advice. From truly listening to patients and nurturing collegial networks to lifelong learning and self-care — this global survey distilled their insights into seven transformative habits and a four-week challenge to help you integrate them into your daily…

Discover more from Family Medicine Initiative

Subscribe now to keep reading and get access to the full archive.

Continue reading